Living meta-analysis and evidence synthesis of therapies for COVID-19

click on circles to display study description...

NCT04342650, 2020 NCT04342650

chloroquine (n=-9) vs. placebo (n=-9)

randomized controlled trial   risk of bias NA

Studied treatment

chloroquine
450 mg x2 day 1, then 450 mg/d for 4 days

Control treatment

placebo

Patients

COVID-19 mild to moderate

Method

double-blind

1 center, Brazil

Remark

found in Axfors et al meta-analysis